Advancing "Organ-on-a-Chip" Technology for Pre-Clinical AAV Safety Testing within the Adeno-associated Virus Vector-based Gene Therapy Sector for Late 2025
The way AAV therapies are tested before they reach human trials is undergoing a radical transformation in late 2025. "Organ-on-a-chip" technology—which uses human cells to recreate the function of a liver, heart, or brain on a microchip—is increasingly being used to predict how a viral vector will behave in a person. This is far more accurate than traditional animal models, as AAV...
0 Комментарии 0 Поделились 205 Просмотры 0 предпросмотр
Спонсоры

Real Profits Start Here – Try Stockity Today!

Experience fast and simple online trading with Stockity. Learn, practice, and trade with real-time market tools designed for everyone — beginners to pros.